Forecast Opportunity View - NHMRC-NIHR 2023

The NHMRC-NIHR Collaborative Research Grant scheme supports Australian participation in international collaborative research through the UK’s National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme.

NHMRC intends to invite Australian researchers listed on successful applications submitted to Stage 1 to apply for NHMRC support of the Australian component of the research under the following topics:

• 22/146 Maintenance treatment for bipolar disorder
• 22/147 Pseudomonas aeruginosa eradication treatment in bronchiectasis
• 22/148 Surgical treatment of proximal ACL ruptures with ACL repair or ACL reconstruction
• 22/150 Intravesical treatments for recurrent urinary tract infection (rUTI) in women
• 22/152 Through-knee versus above-knee major limb amputation
• 22/155 Oral versus intramuscular glucocorticoids in rheumatoid arthritis
• 22/154 Bisphosphonate therapy for Duchenne muscular dystrophy
• 22/156 Children and young people's mental health
• 22/157 Interventions to reduce hospital-based medication administration errors
• 22/158 Inhibition of the renin-angiotensin system in takotsubo cardiomyopathy
• 22/166 Rehabilitation and care following stroke
• 22/167 Imaging pathways for investigation following heart failure diagnosis
• 22/168 The diagnostic accuracy of colon capsule endoscopy

For further information, see NIHR HTA funding page.

GO6182 NHMRC-NIHR Collaborative Research Grant Scheme 2023  |  Closed